VBK.DE
VERBIO Vereinigte BioEnergie AG [VBK.DE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VBK.DE Stock Summary
Top 10 Correlated ETFs
VBK.DE
Top 10 Correlated Stocks
VBK.DE
In the News
VBK.DE Financial details
Company Rating
Strong Buy
Market Cap
1.24B
Income
52.42M
Revenue
1.8B
Book val./share
14.59
Cash/share
1.82
Dividend
0.2
Dividend %
0.75%
Employees
1.38K
Optionable
No
Shortable
Yes
Earnings
14 May 2024
P/E
22.15
Forward P/E
-
PEG
-2.65
P/S
0.91
P/B
1.81
P/C
10.36
P/FCF
-13.59
Quick Ratio
1.4
Current Ratio
2.74
Debt / Equity
0.2
LT Debt / Equity
0.15
-
-
EPS (TTM)
0.82
EPS next Y
-
EPS next Q
-
EPS this Y
-58.32%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
19.88%
Revenue last 5Y
20.36%
Revenue Q/Q
-13.8%
EPS Q/Q
-96.26%
-
-
-
-
SMA20
5.56%
SMA50
-5%
SMA100
-42.42%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
8%
ROC
0.11%
Gross Margin
18%
Oper. Margin
7%
Profit Margin
4%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
16.5-45.84
52W High
-58.11%
52W Low
+17.81%
RSI
47
Rel Volume
1.71
Avg Volume
147.72K
Volume
253.26K
Perf Week
-5.28%
Perf Month
4.09%
Perf Quarter
-44.69%
Perf Half Y
-49.95%
-
-
-
-
Beta
1.086
-
-
Volatility
0.28%, 1.3%
Prev Close
-1%
Price
18.85
Change
-2.38%
VBK.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
| Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 12.37 | 13.85 | 16.27 | 28.66 | 31.03 | |
| Net income per share | 0.84 | 1.01 | 1.48 | 4.99 | 2.08 | |
| Operating cash flow per share | 0.7 | 1.14 | 1.86 | 5.14 | 0.41 | |
| Free cash flow per share | -0.3 | 0.06 | 0.79 | 3.32 | -2.79 | |
| Cash per share | 1.08 | 1.18 | 1.67 | 4.75 | 2.9 | |
| Book value per share | 5.38 | 6.18 | 8.05 | 12.91 | 14.34 | |
| Tangible book value per share | 5.37 | 6.19 | 8.08 | 12.93 | 14.36 | |
| Share holders equity per share | 5.38 | 6.18 | 8.05 | 12.91 | 14.34 | |
| Interest debt per share | 0.17 | 0.79 | 0.76 | 0.83 | 3.02 | |
| Market cap | 493.29M | 589.05M | 2.72B | 3.01B | 2.35B | |
| Enterprise value | 435.32M | 583.41M | 2.66B | 2.76B | 2.37B | |
| P/E ratio | 9.31 | 9.29 | 29.19 | 9.54 | 17.8 | |
| Price to sales ratio | 0.63 | 0.68 | 2.65 | 1.66 | 1.19 | |
| POCF ratio | 11.13 | 8.22 | 23.21 | 9.26 | 90.06 | |
| PFCF ratio | -26.04 | 164.68 | 54.51 | 14.32 | -13.27 | |
| P/B Ratio | 1.45 | 1.51 | 5.36 | 3.69 | 2.58 | |
| PTB ratio | 1.45 | 1.51 | 5.36 | 3.69 | 2.58 | |
| EV to sales | 0.56 | 0.67 | 2.59 | 1.52 | 1.2 | |
| Enterprise value over EBITDA | 4.45 | 4.69 | 14.53 | 5.38 | 9.99 | |
| EV to operating cash flow | 9.82 | 8.14 | 22.71 | 8.49 | 90.82 | |
| EV to free cash flow | -22.98 | 163.1 | 53.34 | 13.13 | -13.38 | |
| Earnings yield | 0.11 | 0.11 | 0.03 | 0.1 | 0.06 | |
| Free cash flow yield | -0.04 | 0.01 | 0.02 | 0.07 | -0.08 | |
| Debt to equity | 0.03 | 0.12 | 0.09 | 0.06 | 0.21 | |
| Debt to assets | 0.02 | 0.09 | 0.07 | 0.04 | 0.15 | |
| Net debt to EBITDA | -0.59 | -0.05 | -0.32 | -0.49 | 0.08 | |
| Current ratio | 2.67 | 2.87 | 2.97 | 2.6 | 2.58 | |
| Interest coverage | 98.12 | 56.57 | 95.21 | 142.69 | 106.51 | |
| Income quality | 0.86 | 1.12 | 1.25 | 1.03 | 0.2 | |
| Dividend Yield | 0.03 | 0.02 | 0 | 0 | 0.01 | |
| Payout ratio | 0.24 | 0.2 | 0.14 | 0.04 | 0.1 | |
| Sales general and administrative to revenue | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0.01 | 0.01 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -1.43 | -0.95 | -0.57 | -0.35 | -7.79 | |
| Capex to revenue | -0.08 | -0.08 | -0.07 | -0.06 | -0.1 | |
| Capex to depreciation | -2.95 | -2.25 | -2.27 | -3.53 | -4.89 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 10.09 | 11.82 | 16.37 | 38.07 | 25.91 | |
| ROIC | 0.15 | 0.14 | 0.17 | 0.36 | 0.12 | |
| Return on tangible assets | 0.12 | 0.12 | 0.14 | 0.28 | 0.1 | |
| Graham Net | 1.1 | 0.72 | 1.61 | 3.34 | 1.03 | |
| Working capital | 131.89M | 166.39M | 243.05M | 404.2M | 384.28M | |
| Tangible asset value | 338.06M | 390.15M | 509.27M | 817.61M | 910.89M | |
| Net current asset value | 124.76M | 117.07M | 197.6M | 346.17M | 241.39M | |
| Invested capital | 0.03 | 0.12 | 0.09 | 0.06 | 0.21 | |
| Average receivables | 64.9M | 83.33M | 122.58M | 167.02M | 182.11M | |
| Average payables | 36.25M | 41.22M | 43.26M | 70.38M | 100.95M | |
| Average inventory | 54.12M | 70.94M | 90.14M | 135.4M | 214.81M | |
| Days sales outstanding | 34.44 | 38.96 | 54.09 | 36.65 | 33.79 | |
| Days payables outstanding | 23.93 | 21.82 | 21.56 | 28.97 | 24.51 | |
| Days of inventory on hand | 36.54 | 41.81 | 48.2 | 51.44 | 59.89 | |
| Receivables turnover | 10.6 | 9.37 | 6.75 | 9.96 | 10.8 | |
| Payables turnover | 15.25 | 16.73 | 16.93 | 12.6 | 14.89 | |
| Inventory turnover | 9.99 | 8.73 | 7.57 | 7.1 | 6.09 | |
| ROE | 0.16 | 0.16 | 0.18 | 0.39 | 0.15 | |
| Capex per share | -1 | -1.08 | -1.07 | -1.82 | -3.2 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 7.66 | 6.98 | 7.04 | 7.69 | 6.62 | |
| Net income per share | 0.4 | 0.35 | 0.12 | 0.34 | 0.01 | |
| Operating cash flow per share | -0.58 | 0.33 | 1.35 | 0.3 | 0.54 | |
| Free cash flow per share | -1.47 | -0.27 | 0.27 | -0.49 | -0.24 | |
| Cash per share | 3.81 | 3.14 | 2.89 | 2.75 | 1.82 | |
| Book value per share | 13.87 | 14.01 | 14.32 | 14.85 | 14.59 | |
| Tangible book value per share | 13.89 | 14.03 | 14.34 | 14.87 | 14.61 | |
| Share holders equity per share | 13.87 | 14.01 | 14.32 | 14.85 | 14.59 | |
| Interest debt per share | 0.81 | 1.53 | 3.01 | 2.79 | 2.99 | |
| Market cap | 3.88B | 2.76B | 2.35B | 2.41B | 1.89B | |
| Enterprise value | 3.81B | 2.72B | 2.37B | 2.47B | 1.96B | |
| P/E ratio | 38.26 | 31.3 | 75.61 | 27.68 | 587.77 | |
| Price to sales ratio | 7.99 | 6.22 | 5.26 | 4.94 | 4.49 | |
| POCF ratio | -106.33 | 129.74 | 27.52 | 124.75 | 55.53 | |
| PFCF ratio | -41.63 | -160.9 | 138.3 | -77.92 | -122.83 | |
| P/B Ratio | 4.41 | 3.1 | 2.59 | 2.56 | 2.04 | |
| PTB ratio | 4.41 | 3.1 | 2.59 | 2.56 | 2.04 | |
| EV to sales | 7.85 | 6.14 | 5.31 | 5.06 | 4.67 | |
| Enterprise value over EBITDA | 70.41 | 66.55 | 79.7 | 53.88 | 58.7 | |
| EV to operating cash flow | -104.49 | 128.14 | 27.75 | 127.58 | 57.71 | |
| EV to free cash flow | -40.91 | -158.92 | 139.46 | -79.69 | -127.66 | |
| Earnings yield | 0.01 | 0.01 | 0 | 0.01 | 0 | |
| Free cash flow yield | -0.02 | -0.01 | 0.01 | -0.01 | -0.01 | |
| Debt to equity | 0.06 | 0.11 | 0.21 | 0.19 | 0.2 | |
| Debt to assets | 0.04 | 0.08 | 0.15 | 0.14 | 0.14 | |
| Net debt to EBITDA | -1.24 | -0.83 | 0.66 | 1.2 | 2.22 | |
| Current ratio | 2.45 | 2.37 | 2.58 | 2.74 | 2.23 | |
| Interest coverage | 143.16 | 92.72 | 13.33 | 37.31 | 3.4 | |
| Income quality | -1.45 | 0.96 | 10.67 | 0.89 | 42.13 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0.58 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0.01 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 1.55 | -1.81 | -0.8 | -2.6 | -1.45 | |
| Capex to revenue | -0.12 | -0.09 | -0.15 | -0.1 | -0.12 | |
| Capex to depreciation | -5.85 | -4 | -5.37 | -4.18 | -3.93 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 11.17 | 10.46 | 6.28 | 10.71 | 2.04 | |
| ROIC | 0.03 | 0.02 | 0.01 | 0.02 | 0 | |
| Return on tangible assets | 0.02 | 0.02 | 0.01 | 0.02 | 0 | |
| Graham Net | 3.81 | 1.75 | 1.03 | 0.71 | -0.26 | |
| Working capital | 379.9M | 367.84M | 384.28M | 374.56M | 331.83M | |
| Tangible asset value | 880.75M | 891.02M | 910.89M | 944.51M | 927.8M | |
| Net current asset value | 332.64M | 319.91M | 241.39M | 232.41M | 189.69M | |
| Invested capital | 0.06 | 0.11 | 0.21 | 0.19 | 0.2 | |
| Average receivables | 192.82M | 183.85M | 155.03M | 154.86M | 153.4M | |
| Average payables | 107.25M | 101.82M | 102.73M | 101.8M | 116.19M | |
| Average inventory | 228.64M | 262.26M | 262.45M | 262.08M | 277.3M | |
| Days sales outstanding | 44.47 | 25.93 | 36.69 | 23.51 | 38.36 | |
| Days payables outstanding | 23.85 | 24.16 | 25.53 | 22.17 | 36.15 | |
| Days of inventory on hand | 59.2 | 64.62 | 62.37 | 60.29 | 77.67 | |
| Receivables turnover | 2.02 | 3.47 | 2.45 | 3.83 | 2.35 | |
| Payables turnover | 3.77 | 3.73 | 3.53 | 4.06 | 2.49 | |
| Inventory turnover | 1.52 | 1.39 | 1.44 | 1.49 | 1.16 | |
| ROE | 0.03 | 0.02 | 0.01 | 0.02 | 0 | |
| Capex per share | -0.89 | -0.6 | -1.08 | -0.79 | -0.78 |
VBK.DE Frequently Asked Questions
What is VERBIO Vereinigte BioEnergie AG stock symbol ?
VERBIO Vereinigte BioEnergie AG is a DE stock and trading under the symbol VBK.DE
What is VERBIO Vereinigte BioEnergie AG stock quote today ?
VERBIO Vereinigte BioEnergie AG stock price is $18.85 today.
Is VERBIO Vereinigte BioEnergie AG stock public?
Yes, VERBIO Vereinigte BioEnergie AG is a publicly traded company.
Company Profile
- Volume Average 147.72K
- Market Capitalization 1.24B
- Employee 1.38K
- CEO Mr. Claus Sauter
- Headquarters Leipzig,DE
- IPO Date 2006-10-16
-
Website
https://www.verbio.de 
VERBIO Vereinigte BioEnergie AG produces and supplies biofuels in Germany and rest of Europe. The company's products include biodiesel, bioethanol, biomethane, biosterol, bioglycerin, and liquid fertilizers. The company offers its products to oil corporations, oil traders, independent filling stations, haulage companies, public utilities, and vehicle fleets. VERBIO Vereinigte BioEnergie AG was founded in 2006 and is headquartered in Leipzig, Germany.
